Sapience Therapeutics
CompanyROR
Founded
Founded
Jan 1, 2015
Sources: ror.org
Trials
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Phase 1, Active, not recruiting, 130 people, May 8, 2023
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Phase 1/2, Active, not recruiting, 125 people, Jul 20, 2020
Sources: clinicaltrials.gov